Back
Neuronetics 10K Form
Sell
28
STIM
Neuronetics
Last Price:
3.58
Seasonality Move:
12.08%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-07 | 10Q | STIM/Neuronetics Quarterly |
2023-08-08 | 10Q | STIM/Neuronetics Quarterly |
2023-05-15 | 10Q | STIM/Neuronetics Quarterly |
2022-11-08 | 10Q | STIM/Neuronetics Quarterly |
2022-08-02 | 10Q | STIM/Neuronetics Quarterly |
2022-05-12 | 10Q | STIM/Neuronetics Quarterly |
Receive STIM News And Ratings
See the #1 stock for the next 7 days that we like better than STIM
STIM Financial Statistics
Sales & Book Value
Annual Sales: | $71.35M |
---|---|
Cash Flow: | $1.25M |
Price / Cash Flow: | 0 |
Annual Sales: | $1.18 |
Price / Book: | 2.99 |
Profitability
EPS (TTM): | -1.07000 |
---|---|
Net Income (TTM): | $-30.19M |
Gross Margin: | $51.71M |
Return on Equity: | -67.68% |
Return on Assets: | -28.5% |
Neuronetics Earnings Forecast
Key Neuronetics Financial Ratios
- The Gross Profit Margin over the past 9 years for STIM is 72.47%.
- The Selling, General & Administrative Expenses for STIM have been equal to 101.96% of Gross Profit Margin.
- The Research & Development expenses have been 13.34% of Revenue.
- The Interest Expense is -15.90% of Operating Income.
- The Net Earning history of STIM is -42.31% of Total Revenues.
- Per Share Earnings over the last 9 years have been positive in 5 years.
Neuronetics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | STIM |
CUSIP: | 64131A |
Website: | neurostar.com |
Debt
Debt-to-Equity Ratio: | 1.73 |
---|---|
Current Ratio: | 4.73 |
Quick Ratio: | 3.96 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
STIM Technical Analysis vs Fundamental Analysis
Sell
28
Neuronetics (STIM)
is a Sell
Is Neuronetics a Buy or a Sell?
-
Neuronetics stock is rated a Sell
The current Neuronetics [STIM] share price is $3.41. The Score for STIM is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.